Santero Therapeutics

Charleroi, Belgium · Founded 2021 · Privately Held (backing)

Developer of antibiotics designed to fight multiple resistant pathogens. Santero Therapeutics is based in Charleroi, Belgium and was founded in 2021. Its last reported valuation was $13.3 million in Mar 2025. It has raised $9.9 million.

Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$9.9M
Last round
—

Who backs Santero Therapeutics?

6 investors
InvestorType
SambrInvestOther
Société Fédérale de Participations et d'InvestissementOther
Université Libre de BruxellesOther
Newton BioCapital—
Pierre Drion—
Wallonie Entreprendre—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Santero Therapeutics investors

6 investors are on record for Santero Therapeutics, including SambrInvest, Société Fédérale de Participations et d'Investissement, Université Libre de Bruxelles and Newton BioCapital.

Free account
More of Santero Therapeutics with a free account
  • ·Watch Santero Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Santero Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View